Related Experiment Video
Updated: May 29, 2026
06:15
Anterior High-Resolution Optical Coherence Tomography in the Diagnosis and Therapeutic Monitoring of Ocular Surface Squamous Neoplasia
Published on: August 9, 2024
Application of TruScreen in detecting ASCUS patients
Weihong Li1, Yu Guo, Haiyan Niu
1Dapartment of Gynaecology and Obstetrics, Affiliated Hospital of Hainan Medical University, Haikou, China.
Asian Pacific Journal of Tropical Medicine
|September 15, 2011
Summary
The TruScreen cervical cancer screening system effectively detects patients with atypical squamous cells of undetermined significance (ASCUS). This system shows improved consistency with pathological results compared to traditional methods, aiding in early diagnosis.
Area of Science:
- Gynecology
- Oncology
- Medical Diagnostics
Background:
- Atypical squamous cells of undetermined significance (ASCUS) represent a common finding in cervical cytology.
- Accurate detection of ASCUS is crucial for timely intervention and prevention of cervical cancer progression.
- Existing screening methods have limitations in sensitivity and specificity for ASCUS detection.
Purpose of the Study:
- To evaluate the efficacy of the TruScreen cervical cancer screening system in identifying patients diagnosed with ASCUS.
- To compare the diagnostic performance of TruScreen with ThinPrep Cytologic Test (TCT) against pathological results.
Main Methods:
- Forty-two patients diagnosed with ASCUS via TCT were included in the study.
- TruScreen was used to analyze samples from specific cervical sites (15-20 and 21-32).
- Results from TruScreen and TCT were compared with histopathological findings from cervical biopsies.
Main Results:
- TruScreen demonstrated a higher positive detection rate (61.91% at site 15-20, 66.67% at site 21-32) compared to TCT's consistency with pathology (38.10%).
- A statistically significant difference was observed in the consistency with pathological results between TruScreen and TCT (P=0.029 and P=0.002).
- TruScreen successfully identified all cases of cervical intraepithelial neoplasia (CIN) II and above, indicating high sensitivity for significant lesions.
Conclusions:
- The TruScreen system is a valuable tool for detecting cervical cancer in patients with ASCUS.
- TruScreen offers improved diagnostic accuracy for ASCUS compared to TCT, particularly for higher-grade lesions.
